
Mariegeorges A. Henry
Examiner (ID: 159, Phone: (571)270-3226 , Office: P/2455 )
| Most Active Art Unit | 2455 |
| Art Unit(s) | 2455, 2155 |
| Total Applications | 638 |
| Issued Applications | 457 |
| Pending Applications | 59 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7088908
[patent_doc_number] => 20050009021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Retinoic acid metabolizing cytochrome p450'
[patent_app_type] => utility
[patent_app_number] => 10/477526
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 30410
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10477526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477526 | Retinoic acid metabolizing cytochrome P450 | May 22, 2002 | Issued |
Array
(
[id] => 6323898
[patent_doc_number] => 20020197253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Compositions and methods for promoting or inhibiting NDPK'
[patent_app_type] => new
[patent_app_number] => 10/153153
[patent_app_country] => US
[patent_app_date] => 2002-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12371
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153153 | Compositions and methods for promoting or inhibiting NDPK | May 21, 2002 | Abandoned |
Array
(
[id] => 6656520
[patent_doc_number] => 20030077729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Novel secretion factors for gram-positive micoorganisms, genes encoding them and methods of using it'
[patent_app_type] => new
[patent_app_number] => 10/147936
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7196
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147936 | Secretion factors for gram-positive micoorganisms, genes encoding them and methods of using it | May 16, 2002 | Issued |
Array
(
[id] => 383207
[patent_doc_number] => 07307159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Heparin/heparosan synthase from P. multocida and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 10/142143
[patent_app_country] => US
[patent_app_date] => 2002-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 7
[patent_no_of_words] => 15432
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/307/07307159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10142143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/142143 | Heparin/heparosan synthase from P. multocida and methods of making and using same | May 7, 2002 | Issued |
| 10/048872 | Production of proteins by autoproteolytic cleavage | May 2, 2002 | Abandoned |
| 10/129280 | Human transferase molecules | Apr 29, 2002 | Abandoned |
Array
(
[id] => 6260150
[patent_doc_number] => 20020187525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Method of producing microbial transglutaminase'
[patent_app_type] => new
[patent_app_number] => 10/124429
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4374
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124429 | Method of producing microbial transglutaminase | Apr 17, 2002 | Abandoned |
Array
(
[id] => 1314979
[patent_doc_number] => 06607892
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-19
[patent_title] => '21529, a novel adenylate cyclase'
[patent_app_type] => B2
[patent_app_number] => 10/121911
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 35414
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/607/06607892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121911 | 21529, a novel adenylate cyclase | Apr 11, 2002 | Issued |
Array
(
[id] => 956363
[patent_doc_number] => 06956114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-18
[patent_title] => 'Sulfurylase-luciferase fusion proteins and thermostable sulfurylase'
[patent_app_type] => utility
[patent_app_number] => 10/122706
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17009
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/956/06956114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122706 | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase | Apr 10, 2002 | Issued |
Array
(
[id] => 540982
[patent_doc_number] => 07169592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Producing optically active amino compounds'
[patent_app_type] => utility
[patent_app_number] => 10/112706
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16024
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169592.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112706 | Producing optically active amino compounds | Apr 1, 2002 | Issued |
Array
(
[id] => 6874493
[patent_doc_number] => 20030194790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'DNA sequences coding for ester-group-cleaving enzymes'
[patent_app_type] => new
[patent_app_number] => 10/102239
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4700
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194790.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102239 | DNA sequences coding for ester-group-cleaving enzymes | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6756529
[patent_doc_number] => 20030004306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Fluorescent protein'
[patent_app_type] => new
[patent_app_number] => 10/086738
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11872
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004306.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086738 | Fluorescent protein | Mar 3, 2002 | Abandoned |
Array
(
[id] => 909861
[patent_doc_number] => 07329524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Agarase and gene thereof'
[patent_app_type] => utility
[patent_app_number] => 10/467824
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18759
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467824 | Agarase and gene thereof | Feb 25, 2002 | Issued |
Array
(
[id] => 1005437
[patent_doc_number] => 06906033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-14
[patent_title] => 'Protease inhibitor peptides'
[patent_app_type] => utility
[patent_app_number] => 10/076604
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 17916
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076604 | Protease inhibitor peptides | Feb 18, 2002 | Issued |
Array
(
[id] => 6433624
[patent_doc_number] => 20020127695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Chemically modified enzymes with multiple charged variants'
[patent_app_type] => new
[patent_app_number] => 10/075907
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 32955
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075907 | Chemically modified enzymes with multiple charged variants | Feb 11, 2002 | Abandoned |
| 10/049797 | Isomerase proteins | Feb 11, 2002 | Abandoned |
Array
(
[id] => 6433239
[patent_doc_number] => 20020127664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/067291
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19909
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067291 | Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof | Feb 6, 2002 | Issued |
Array
(
[id] => 6720843
[patent_doc_number] => 20030054531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Human stroke gene'
[patent_app_type] => new
[patent_app_number] => 10/067514
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 368
[patent_figures_cnt] => 368
[patent_no_of_words] => 30788
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067514 | Human stroke gene | Feb 3, 2002 | Abandoned |
| 09/936028 | Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates | Jan 30, 2002 | Abandoned |
Array
(
[id] => 6692660
[patent_doc_number] => 20030040092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Transaminases and aminotranferases'
[patent_app_type] => new
[patent_app_number] => 10/060432
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8165
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040092.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060432 | Transaminases and aminotranferases | Jan 28, 2002 | Abandoned |